Michael Barbella, Managing Editor08.05.22
Artificial intelligence (AI) is expected to disrupt the U.S. women’s healthcare market as medical device companies spend $500 million on artificial intelligence (AI) platforms by 2024, up from $200 million in 2019, according to GlobalData.
The market is forecast to expand 20.6% annually. Diagnostic tools such as Ultrasound AI’s Preterm AI (PAI), designed to predict preterm birth (PTB), will disrupt the prenatal market providing assistance to sonographers.
According to GlobalData’s report, "Prenatal Screening Market Size by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030," prenatal screenings will continue to account for the majority of revenue in North America’s women’s health market, which was valued at $148.6 million in 2015 and is expected to reach $170.4 million in 2025.
“While AI will not replace sonographers, it will certainly be disruptive to the market. It will be a valuable teaching tool and support testing and validation. Imaging professionals can help drive the technology’s advancements, as it requires skilled sonographers to facilitate the right decision and assessment paths,” said Cynthia Stinchcombe, a medical devices analyst at GlobalData.
AI is also making waves in the healthcare industry at large, with the market set to reach $4.3 billion by 2024, up from $1.5 billion in 2019.
The market is forecast to expand 20.6% annually. Diagnostic tools such as Ultrasound AI’s Preterm AI (PAI), designed to predict preterm birth (PTB), will disrupt the prenatal market providing assistance to sonographers.
According to GlobalData’s report, "Prenatal Screening Market Size by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030," prenatal screenings will continue to account for the majority of revenue in North America’s women’s health market, which was valued at $148.6 million in 2015 and is expected to reach $170.4 million in 2025.
“While AI will not replace sonographers, it will certainly be disruptive to the market. It will be a valuable teaching tool and support testing and validation. Imaging professionals can help drive the technology’s advancements, as it requires skilled sonographers to facilitate the right decision and assessment paths,” said Cynthia Stinchcombe, a medical devices analyst at GlobalData.
AI is also making waves in the healthcare industry at large, with the market set to reach $4.3 billion by 2024, up from $1.5 billion in 2019.
